← Eichor
Condition: Refractory Status Epilepticus Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Refractory Status Epilepticus

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest
Phase 2 · 1 location(s) · University of California, San Francisco · NCT05851391KD Treatment for Super-refractory Status Epilepticus
NA · 14 location(s) · Xuanwu Hospital, Beijing · NCT07496749Levetiracetam Versus Phenobarbital in Benzodiazepines Unresponsive Paediatric Prolonged Seizures
NA · 2 location(s) · Ministry of Health and Sports, Myanmar · NCT07098728Sustained Effort Network for Treatment of Status Epilepticus/European Academy of Neurology Registry on Refractory Status
Phase N/A · 11 location(s) · Erasme University Hospital · NCT05839418EEG Monitoring for Refractory Status Epilepticus
NA · 1 location(s) · Barts & The London NHS Trust · NCT04170491Application of tDCS Stimulation in Controlling Refractory Status Epilepticus
NA · 1 location(s) · Xuanwu Hospital, Beijing · NCT06344338Exogenous Ketone Esters for Refractory Status Epileptics
Phase 2/Phase 3 · 1 location(s) · Sohag University · NCT05674552
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.